院外心脏骤停后氧合目标与6个月结局:TTM2试验的预先设定亚组分析
该研究为TTM2试验的预先设定二次分析,纳入1418例院外心脏骤停(OHCA)患者,随机化后前32小时每4小时、之后至第3天每8小时采集动脉血气。低氧血症定义为PaO2<60 mmHg,严重高氧血症定义为PaO2>300 mmHg。24.9%患者至少发生一次低氧血症,7.6%至少发生一次严重高氧血症;两者均与6个月死亡率独立相关,但与神经功能不良结局无关。与6个月死亡率相关的最佳切点:低氧血症为69 mmHg(RR=1.009,95%CI 0.93-1.09),高氧血症为195 mmHg(RR=1.006,95%CI 0.95-1.06);高氧血症的时间暴露(PaO2-AUC)与死亡率显著相关(p=0.003)。
要点
- OHCA患者中24.9%至少发生一次低氧血症(PaO2<60 mmHg),7.6%至少发生一次严重高氧血症(PaO2>300 mmHg)。
- 低氧血症与高氧血症均与6个月死亡率独立相关,但均与神经功能不良结局无关。
- 与6个月死亡率相关的最佳切点:低氧血症69 mmHg(RR=1.009,95%CI 0.93-1.09),高氧血症195 mmHg(RR=1.006,95%CI 0.95-1.06)。
- 高氧血症的时间暴露(PaO2-AUC)与死亡率显著相关(p=0.003),效应由暴露时间介导。
- 作者认为对该组患者应考虑精确滴定氧合水平。
适用人群与场景
- 院外心脏骤停(OHCA)复苏后接受机械通气的患者,纳入TTM2试验并进入本预先设定二次分析者。
诊断标准与关键阈值
- 低氧血症定义:PaO2<60 mmHg。
- 严重高氧血症定义:PaO2>300 mmHg。
- 与6个月死亡率相关的最佳切点:低氧血症69 mmHg,高氧血症195 mmHg。
- 神经功能不良结局按改良Rankin量表(modified Rankin scale)定义。
处置流程与药物剂量
- 随机化后前32小时每4小时采集动脉血气,之后每8小时采集直至第3天。
研究设计与关键结果
- 研究类型:TTM2试验的预先设定二次分析;样本量1418例;平均年龄64±14岁;女性292例(20.6%)。
- 24.9%患者至少发生一次低氧血症,7.6%患者至少发生一次严重高氧血症。
- 低氧血症与高氧血症均与6个月死亡率独立相关,但均与神经功能不良结局无关。
- 与6个月死亡率相关的最佳切点:低氧血症69 mmHg(RR=1.009,95%CI 0.93-1.09);高氧血症195 mmHg(RR=1.006,95%CI 0.95-1.06)。
- 高氧血症的时间暴露(PaO2-AUC)与死亡率显著相关(p=0.003)。
证据类型、等级与局限
- 证据类型:随机对照试验(TTM2)的预先设定二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,OHCA患者中低氧血症和高氧血症均与6个月死亡率相关,效应由高氧暴露时间介导,应考虑对该组患者精确滴定氧合水平。
指南或共识出处
- TTM2试验(targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest),ClinicalTrials.gov注册号NCT02908308,注册日期2016年9月20日。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Optimal oxygen targets in patients resuscitated after cardiac arrest are uncertain. The primary aim of this study was to describe the values of partial pressure of oxygen values (PaO2) and the episodes of hypoxemia and hyperoxemia occurring within the first 72 h of mechanical ventilation in out of hospital cardiac arrest (OHCA) patients. The secondary aim was to evaluate the association of PaO2 with patients' outcome.
METHODS: Preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after OHCA (TTM2) trial. Arterial blood gases values were collected from randomization every 4 h for the first 32 h, and then, every 8 h until day 3. Hypoxemia was defined as PaO2 < 60 mmHg and severe hyperoxemia as PaO2 > 300 mmHg. Mortality and poor neurological outcome (defined according to modified Rankin scale) were collected at 6 months.
RESULTS: 1418 patients were included in the analysis. The mean age was 64 ± 14 years, and 292 patients (20.6%) were female. 24.9% of patients had at least one episode of hypoxemia, and 7.6% of patients had at least one episode of severe hyperoxemia. Both hypoxemia and hyperoxemia were independently associated with 6-month mortality, but not with poor neurological outcome. The best cutoff point associated with 6-month mortality for hypoxemia was 69 mmHg (Risk Ratio, RR = 1.009, 95% CI 0.93-1.09), and for hyperoxemia was 195 mmHg (RR = 1.006, 95% CI 0.95-1.06). The time exposure, i.e., the area under the curve (PaO2-AUC), for hyperoxemia was significantly associated with mortality (p = 0.003).
CONCLUSIONS: In OHCA patients, both hypoxemia and hyperoxemia are associated with 6-months mortality, with an effect mediated by the timing exposure to high values of oxygen. Precise titration of oxygen levels should be considered in this group of patients.
TRIAL REGISTRATION: clinicaltrials.gov NCT02908308 , Registered September 20, 2016.
参考来源
- Robba C, Badenes R, Battaglini D, et al. Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Crit Care. 2022. PMID: 36271410. doi:10.1186/s13054-022-04186-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。